Malignant degeneration in leiomyomatosis peritonealis disseminata

Gynecol Oncol. 1996 May;61(2):272-4. doi: 10.1006/gyno.1996.0138.

Abstract

Leiomyomatosis peritonealis disseminata (LPD) is a rare clinico-pathologic entity typically observed in women of reproductive age. Its malignant degeneration has been reported in literature in only three cases. In this report we describe the clinical course of two more cases with proved malignant transformation of LPD; both cases were treated with combined chemotherapy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cell Transformation, Neoplastic
  • Dacarbazine / therapeutic use
  • Epirubicin / therapeutic use
  • Female
  • Humans
  • Ifosfamide / therapeutic use
  • Leiomyomatosis / drug therapy
  • Leiomyomatosis / pathology*
  • Middle Aged
  • Peritoneal Neoplasms / drug therapy
  • Peritoneal Neoplasms / pathology*

Substances

  • Epirubicin
  • Dacarbazine
  • Ifosfamide

Supplementary concepts

  • EID protocol